EUVIMEDScopri EUVIMED
Crossref

Mendelian randomization study of lipid metabolism characteristics and migraine risk

Peiwei Hong iD, Lin Han, Yang Wan

European Journal of Pain · 2024

DOI: 10.1002/ejp.2235 ↗

At a glance

Journal article in European Journal of Pain, 2024. Written by Peiwei Hong and 2 co-authors. Institution: Department of Neurology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, People's Republic of China. Major MEDLINE topics: Mendelian Randomization Analysis, Polymorphism, Single Nucleotide, Genome-Wide Association Study, Lipid Metabolism. Cited 8 times so far (Crossref); 40 references.

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

The association between serum lipids and migraine is controversial. However, randomized controlled trials have suggested that statins may be efficacious for the prevention of migraine. In this study, we aim to investigate the relationship between lipids metabolism and migraine risk.

Methods

Single‐nucleotide polymorphisms (SNPs), relating to the serum lipid traits and the effect of lipid‐lowering drugs that target APOB , CETP , HMGCR , NPC1L1 , and PCSK9 , were extracted from genome‐wide association studies (GWAS) summary data. The GWAS summary data were obtained from the Global Lipids Genetic Consortium (GLGC), the UK Biobank, and the FinnGen study, respectively. Mendelian randomization (MR) analysis was performed to evaluate the association between serum lipid traits and lipid‐lowering drugs with migraine risk.

Results

Regarding serum lipids, it was found that SNPs related to high‐density lipoprotein cholesterol (HDL‐C), low‐density lipoprotein cholesterol (LDL‐C), non‐high‐density lipoprotein cholesterol (non‐HDL‐C), total cholesterol (TC), or triglycerides (TG) levels were not associated with migraine, migraine with aura (MA) or migraine without aura (MO). In addition, genotypes of HMGCR related to higher LDL‐C levels were associated with increased risk of migraine (OR = 1.46, p = 0.035) and MA (OR = 2.03, p = 0.008); However, genotypes of PCSK9 related to higher LDL‐C levels were associated with decreased risk of migraine (OR = 0.75, p = 0.001) and MA (OR = 0.69, p = 0.004); And genotypes of APOB related to higher LDL‐C levels were associated with decreased risk of MO (OR = 0.62, p = 0.000).

Conclusions

There is a relationship between lipid metabolism characteristics and migraine risk. Significance Based on the genome‐wide association summary data, single‐nucleotide polymorphisms (SNPs) related to high‐density lipoprotein cholesterol (HDL‐C), low‐density lipoprotein cholesterol (LDL‐C), non‐high‐density lipoprotein cholesterol (non‐HDL‐C), total cholesterol (TC), or triglycerides (TG) level were not associated with risk of migraine, migraine with aura (MA) or migraine without aura (MO). However, genotypes of HMGCR related to higher LDL‐C levels have shown an increased risk on migraine and MA. And genotypes of APOB or PCSK9 related to higher LDL‐C levels have shown a decreased risk on MO, or migraine and MA, respectively. These results suggested that there may be a relationship between lipid metabolism characteristics and the risk for migraine development.

Subjects

MeSH terms (MEDLINE)

Mendelian Randomization AnalysisPolymorphism, Single NucleotideGenome-Wide Association StudyLipid MetabolismMigraine DisordersHydroxymethylglutaryl CoA ReductasesHumansProprotein Convertase 9Cholesterol Ester Transfer ProteinsMigraine with AuraCholesterol, LDLRisk FactorsLipidsTriglyceridesCholesterol, HDLMigraine without AuraMembrane Transport ProteinsApolipoprotein B-100

Substances

HMGCR protein, humanHydroxymethylglutaryl CoA ReductasesProprotein Convertase 9PCSK9 protein, humanCholesterol Ester Transfer ProteinsNPC1L1 protein, humanCETP protein, humanCholesterol, LDLLipidsTriglycerides

Authors and institutions

  • Department of Neurology, West China School of Public Health and West China Fourth Hospital, Sichuan University, Chengdu, People's Republic of China.
  • West China-PUMC C.C. Chen Institute of Health, Sichuan University, Chengdu, People's Republic of China.

ORCID profiles: Peiwei Hong

Cite

APA

Hong, P., Han, L., & Wan, Y. (2024). Mendelian randomization study of lipid metabolism characteristics and migraine risk. European Journal of Pain. https://doi.org/10.1002/ejp.2235

Vancouver

Hong P, Han L, Wan Y. Mendelian randomization study of lipid metabolism characteristics and migraine risk. European Journal of Pain. 2024. doi:10.1002/ejp.2235

BibTeX
@article{Hong2024,
  author = {Hong, Peiwei and Han, Lin and Wan, Yang},
  title = {Mendelian randomization study of lipid metabolism characteristics and migraine risk},
  journal = {European Journal of Pain},
  year = {2024},
  doi = {10.1002/ejp.2235}
}
Start for free →